Evidence map›Paper›PMID 29643330›Full record

ArticleNature communications2018

Publisher Correction: Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity.

Will J R Stone, Joseph J Campo, André Lin Ouédraogo, Lisette Meerstein-Kessel, Isabelle Morlais, Dari Da, Anna Cohuet, Sandrine Nsango, Colin J Sutherland, Marga van de Vegte-Bolmer and 24 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors.

Will J R StoneRadboud Institute for Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. william.stone@lshtm.ac.uk.
Joseph J CampoAntigen Discovery Inc., 92618, Irvine, CA, USA.
André Lin OuédraogoInstitute for Disease Modeling, 3150 139th Ave SE, 98005, Bellevue, WA, USA.
Lisette Meerstein-KesselRadboud Institute for Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
Isabelle MorlaisOrganisation de Coordination pour la lutte contre les Endémies en Afrique Centrale, BP 288, Yaoundé, Cameroon.
Dari DaInstitut de Recherche en Sciences de la Santé, 399 Avenue de la Liberté, 01 BP 545, Bobo-Dioulasso, Burkina Faso.
Anna CohuetInstitut de Recherche pour le Développement, MIVEGEC (IRD, CNRS, Univ. Montpellier), 911 Avenue Agropolis, 34394, Montpellier, France.ORCID http://orcid.org/0000-0002-1876-5656
Sandrine NsangoOrganisation de Coordination pour la lutte contre les Endémies en Afrique Centrale, BP 288, Yaoundé, Cameroon.
Colin J SutherlandDepartment of Immunology and Infection, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT, London, UK.
Marga van de Vegte-BolmerRadboud Institute for Molecular Life Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
Rianne Siebelink-StoterRadboud Institute for Molecular Life Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
Geert-Jan van GemertRadboud Institute for Molecular Life Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
Wouter GraumansRadboud Institute for Molecular Life Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
Kjerstin LankeRadboud Institute for Molecular Life Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
Adam D ShandlingAntigen Discovery Inc., 92618, Irvine, CA, USA.
Jozelyn V PabloAntigen Discovery Inc., 92618, Irvine, CA, USA.
Andy A TengAntigen Discovery Inc., 92618, Irvine, CA, USA.
Sophie JonesDepartment of Immunology and Infection, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT, London, UK.
Roos M de JongRadboud Institute for Molecular Life Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
Amanda Fabra-GarcíaRadboud Institute for Molecular Life Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
John BradleyMedical Research Council Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT, London, UK.
Will RoeffenRadboud Institute for Molecular Life Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
Edwin LasonderSchool of Biomedical and Healthcare Sciences, Plymouth University, Drakes Circus, PL4 8AA, Plymouth, UK.
Giuliana GremoDepartment of Oncology, University of Torino, Via Santena 5bis, 10126, Torino, Italy.
Evelin SchwarzerDepartment of Oncology, University of Torino, Via Santena 5bis, 10126, Torino, Italy.ORCID http://orcid.org/0000-0003-2791-1894
Chris J JanseDepartment of Parasitology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
Susheel K SinghDepartment for Congenital Diseases, Statens Serum Institut, DK 2300, Copenhagen, Denmark.
Michael TheisenDepartment for Congenital Diseases, Statens Serum Institut, DK 2300, Copenhagen, Denmark.
Phil FelgnerDepartment of Medicine, University of California Irvine, 92697, Irvine, CA, USA.
Matthias MartiDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, 02115, Boston, MA, USA.
Chris DrakeleyDepartment of Immunology and Infection, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT, London, UK.
Robert SauerweinRadboud Institute for Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
Teun BousemaRadboud Institute for Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. teun.bousema@radboudumc.nl.
Matthijs M JoreRadboud Institute for Molecular Life Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.

Funding

Medical Research Council MR/K012126/1
6 · The paper itself

Abstract

The original version of this Article contained errors in Fig. 3. In panel a, bars from a chart depicting the percentage of antibody-positive individuals in non-infectious and infectious groups were inadvertently included in place of bars depicting the percentage of infectious individuals, as described in the Article and figure legend. However, the p values reported in the Figure and the resulting conclusions were based on the correct dataset. The corrected Fig. 3a now shows the percentage of infectious individuals in antibody-negative and -positive groups, in both the PDF and HTML versions of the Article. The incorrect and correct versions of Figure 3a are also presented for comparison in the accompanying Publisher Correction as Figure 1.The HTML version of the Article also omitted a link to Supplementary Data 6. The error has now been fixed and Supplementary Data 6 is available to download.

Identifiers

PMID29643330
PMCPMC5895811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.